Bristol-Myers worldwide medical group to be headed by Kenneth Weg.
This article was originally published in The Tan Sheet
Executive Summary
BRISTOL-MYERS WORLDWIDE MEDICINES GROUP TO BE LED BY WEG, effective Jan 1. Kenneth Weg, who now serves as an exec VP and president of Bristol-Myers Squibb's pharmaceutical group, will be president of the worldwide medicines group, which encompasses worldwide consumer medicines, worldwide pharmaceuticals and the Central and Eastern Europe business unit.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning